Rallis India delivered a resilient FY26, achieving its highest-ever EBITDA of ₹362 Cr, up 26%. Full-year revenue grew 9% to ₹2,897 Cr, with profit (PAT) surging 47% to ₹184 Cr.

Q4 saw revenue climb 6% to ₹456 Cr, with significant improvement in EBITDA and PAT from prior negative figures.

Domestic formulations revenue grew 5% despite challenging market conditions, while the Seeds business jumped 23% in Q4, though B2B exports/CSM declined 8%. Strategic focus includes customer centricity, digital initiatives, and alliances to widen reach, expand portfolio, intensify custom synthesis, and boost Soil & Plant Health solutions, alongside cost competitiveness.

Recent highlights include 11 new Domestic Formulations products, 19 new Seeds products, and registration for Spiro, a patented paddy herbicide.

Management is building a roadmap for a growing, capital-efficient, and sustainable future.